Skip to main content

Table 2 Correlation between end-stage renal disease patients’ clinical features and erythropoietin (EPO) responsiveness

From: V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

  EPO responders EPO non-responders P valuea
Age (yr) 59.0 ± 10.8 56.7 ± 9.3 0.746
Ferritin (mg/dL) 262.2 ± 117.3 430.7 ± 326.5 0.327
Fe (μg/dL) 71.8 ± 22.8 61.7 ± 17.9 0.507
TIBC (μg/dL) 258.0 ± 22.0 228 ± 3.6 0.080
Alb (g/dL) 4.2 ± 0.3 4.4 ± 0.1 0.355
MCV (fL) 92.8 ± 4.3 91.3 ± 2.1 0.584
PTH (pg/mL) 256.8 ± 102.1 455.3 ± 320.1 0.248
Kt/V 1.4 ± 0.3 1.6 ± 0.3 0.506
Hb (g/dL) 11.7 ± 0.9 9.9 ± 0.6 0.048b
  1. a P values were calculated by asymptotic two-sample Fisher-Pitman permutation test. TIBC total iron-binding capacity, Alb albumin, MCV mean corpuscular volumn, PTH parathyroid hormone, Kt/V (dialyzer clearance of urea)×(dialysis time)/(volume of distribution of urea); Hb, hemoglobin. b P-value < 0.05